“Cytomegalovirus Genetic Diversity Following Primary Infection.”. J Infect Dis 221 (5). J Infect Dis: 715-720. doi:10.1093/infdis/jiz507.
. 2020. “A Phase I Trial To Evaluate The Safety And Immunogenicity Of Wrss2 And Wrss3; Two Live Oral Candidate Vaccines Against Shigella Sonnei.”. Vaccine 36 (32 Pt B). Vaccine: 4880-4889. doi:10.1016/j.vaccine.2018.06.063.
. 2018. “Safety And Immunogenicity Of A Parenteral P2-Vp8-P[8] Subunit Rotavirus Vaccine In Toddlers And Infants In South Africa: A Randomised, Double-Blind, Placebo-Controlled Trial.”. Lancet Infect Dis 17 (8). Lancet Infect Dis: 843-853. doi:10.1016/S1473-3099(17)30242-6.
. 2017. “Safety And Immunogenicity Of A Parenterally Administered Rotavirus Vp8 Subunit Vaccine In Healthy Adults.”. Vaccine 33 (31). Vaccine: 3766-72. doi:10.1016/j.vaccine.2015.05.024.
. 2015. “Safety And Immunogenicity Of Sequential Rotavirus Vaccine Schedules.”. Pediatrics 137 (2). Pediatrics: e20152603. doi:10.1542/peds.2015-2603.
. 2016.